TITLE

Neuropsychiatric symptoms in patients with Parkinson's disease and dementia: frequency, profile and associated care giver stress

AUTHOR(S)
Aarsland, D.; Br&3x00F8;nnick, K.; Ehrt, U.; De Deyn, P. P.; Tekin, S.; Emre, M.; Cummings, J. I.
PUB. DATE
January 2007
SOURCE
Journal of Neurology, Neurosurgery & Psychiatry;Jan2007, Vol. 78 Issue 1, p36
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Objective: To explore the profile of neuropsychiatric symptoms in patients with dementia associated with Parkinson's disease (PDD). Methods: 537 patients with PDD drawn from an international multicentre clinical trial of rivastigmine were assessed using the 10-item Neuropsychiatric Inventory (NPI). A cluster analysis was used to investigate the inter-relationship of NPI items. Associations between the clusters and demographic and clinical variables were analysed. Results: 89% of the patients presented at least one symptom on the NPI, 77% had two or more symptoms and 64% had at least one symptom with a score ⩾4. The most common symptoms were depression (58%), apathy (54%), anxiety (49%) and hallucinations (44%). Patients with more severe dementia and advanced Parkinson's disease had more neuropsychiatric symptoms. Nearly 60% of the care givers reported at least one NPI symptom to be of at least moderate severe distress. Five NPI clusters were identified: one group with few and mild symptoms (52%); a mood cluster (11%, high scores on depression, anxiety and apathy); apathy (24%; high apathy and low scores on other items); agitation (5%, high score on agitation and high total NPI score); and a psychosis cluster (8%; high scores on delusions and hallucinations). The psychosis and agitation clusters had the lowest Mini-Mental State Examination score and the highest Unified Parkinson's Disease Rating Scale and care giver distress scores. Conclusion: Neuropsychiatric symptoms are common in patients with PDD. The profile of these symptoms differs from that in other types of dementia. Subgroups with different neuropsychiatric profiles were identified. These subgroups may be associated with distinct neurobiological changes, which should be explored in future studies.
ACCESSION #
23593619

 

Related Articles

  • Capgras Syndrome Heralding the Development of Dementia. Lipkin, Bron // British Journal of Psychiatry;Jul88, Vol. 153, p117 

    Delusional misidentification of people otherwise well known, referred to as the Capgras syndrome, has been described in both functional and organic conditions. Evidence is accruing to suggest that it would always be prudent to search vigorously for an organic aetiology.

  • Dementia with Lewy Bodies: An Emerging Disease. Neef, Doug; Walling, Anne D. // American Family Physician;4/1/2006, Vol. 73 Issue 7, p1223 

    Dementia with Lewy bodies appears to be the second most common form of dementia, accounting for about one in five cases. The condition is characterized by dementia accompanied by delirium, visual hallucinations, and parkinsonism. Other common symptoms include syncope, falls, sleep disorders, and...

  • The Charles Bonnet syndrome: a case report and a brief review. Saiz González, D.; Díaz Marsá, M. // Actas Espanolas de Psiquiatria;jan2003, Vol. 31 Issue 1, p48 

    The Charles Bonnet syndrome (CBS) is a rare disease that also seems to be generally misdiagnosed. Initially described in the XVIII century by the philosopher with the same name, it consist in complex visual hallucinations in elderly people who suffer sensory deprivation with no other...

  • The early course of affective and cognitive symptoms in de novo patients with Parkinson's disease. Spalletta, Gianfranco; Robinson, Robert; Cravello, Luca; Pontieri, Francesco; Pierantozzi, Mariangela; Stefani, Alessandro; Long, Jeffrey; Caltagirone, Carlo; Assogna, Francesca // Journal of Neurology;Jun2014, Vol. 261 Issue 6, p1126 

    Neuropsychiatric and cognitive symptoms are common in patients with Parkinson's disease (PD) from the early stage of the disease but their course is still unclear. In this study we investigated prospectively the progression of affective and cognitive symptoms and disorders in de novo idiopathic...

  • A clinico-pathological study of subtypes in Parkinson's disease. Selikhova, M.; Williams, D. R.; Kempster, P. A.; Holton, J. L.; Revesz, T.; Lees, A. J. // Brain: A Journal of Neurology;Nov2009, Vol. 132 Issue 11, p2947 

    We have carried out a systematic review of the case files of 242 donors with pathologically verified Parkinson's disease at the Queen Square Brain Bank for Neurological Disorders in an attempt to corroborate the data-driven subtype classification proposed by Lewis and colleagues (Heterogeneity...

  • Cholinesterase inhibitors for treatment of dementia associated with Parkinson's disease. Cummings, Jeffrey L.; Cummings, J L // Journal of Neurology, Neurosurgery & Psychiatry;Jul2005, Vol. 76 Issue 7, p903 

    This article cites studies related to the use of cholinesterase inhibitors for the treatment of dementia associated with Parkinson's disease (PD). Several studies also indicate that cholinesterase inhibitors may reduce neuropsychiatric symptoms in PD, particularly hallucinations and delusions....

  • Drugs minimally effective for neuropsychiatric symptoms of dementia.  // Journal of Family Practice;May2005, Vol. 54 Issue 5, p407 

    The article presents information on the usefulness of the various pharmacological agents in the management of neuropsychiatry symptoms of dementia. Pharmacological agents are minimally, if at all, effective in managing the neuropsychiatry symptoms of dementia. The atypical antypsychotics...

  • An Empirical Study of Delirium Subtypes. Liptzin, Benjamin; Levkoff, Sue E. // British Journal of Psychiatry;Dec92, Vol. 161, p843 

    Using a structured instrument, 325 elderly patients admitted to a general hospital for an acute medical problem were evaluated daily in order to detect symptoms of delirium. Patients were scored for 'hyperactive' or 'hypoactive' symptoms, and then the 125 patients with DSM-lll delirium were...

  • Functional involvement of central cholinergic circuits and visual hallucinations in Parkinson's disease. Manganelli, Fiore; Vitale, Carmine; Santangelo, Gabriella; Pisciotta, Chiara; Iodice, Rosa; Cozzolino, Autilia; Dubbioso, Raffaele; Picillo, Marina; Barone, Paolo; Santoro, Lucio // Brain: A Journal of Neurology;Sep2009, Vol. 132 Issue 9, p2350 

    Visual hallucinations (VHs) represent a frequent and disturbing complication of Parkinson's disease. Evidence suggests that VH can be related to central cholinergic dysfunction. Short-latency afferent inhibition (SAI) technique gives the opportunity to test an inhibitory cholinergic circuit in...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics